Peer AI

Peer AI operates as a specialized artificial intelligence platform focused on the life sciences sector, specifically targeting the $15 billion regulatory documentation market. Founded in 2023 by a team of industry veterans, including CEO Anita Modi, COO Christopher Ceppi, and CSO Ravi Ramachandran, the San Francisco-based company aims to streamline and accelerate the creation of complex regulatory filings for pharmaceutical, biotechnology, and contract research organizations (CROs). The founders' collective experience in AI and life sciences underpins the company's strategy. Modi, for instance, transitioned from a scientist to an entrepreneur, leveraging her industry background to address the historically underserved and overburdened field of medical writing.

The company's core offering is an agentic AI platform that automates the generation of regulatory documents, which are critical for the drug approval process. This process is notoriously cumbersome, with a single new drug requiring over 1,500 unique documents totaling more than 200,000 pages. Peer AI's technology deploys purpose-built AI agents to handle various stages of document creation, such as data extraction from complex sources, drafting content, ensuring compliant formatting, and performing final validation checks. The platform is engineered to produce documents like clinical study reports (CSRs), investigational new drug (IND) applications, and investigator's brochures (IBs), with reported drafting time reductions of up to 94%. Revenue is generated by providing this platform to clients, which include top 20 pharmaceutical companies and emerging biotechs.

A key feature of Peer AI's system is its human-in-the-loop design, which combines AI automation with strategic control points for medical writers and subject matter experts. This approach allows experts to maintain oversight, verify content, and ensure the integrity and quality of the final documentation, rather than being replaced by automation. The company has demonstrated significant market traction, with a threefold increase in daily active use and a sixfold growth in platform volume in the first three quarters of 2025. To fuel its product development and commercial expansion, Peer AI secured $12.1 million in a Series B funding round led by Flare Capital Partners and SignalFire, with participation from other venture firms and strategic angel investors.

Keywords: agentic AI, regulatory documentation, life sciences, medical writing automation, clinical study reports, IND applications, drug approval process, biotech, pharmaceutical industry, human-in-the-loop AI, clinical trial documentation, regulatory compliance, AI for pharma, Flare Capital Partners, SignalFire, Anita Modi, Christopher Ceppi, regulatory submission, document automation, CRO services, data extraction AI